2014 Q4 Form 10-Q Financial Statement

#000146310114000021 Filed on November 05, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $105.2M $99.11M $62.05M
YoY Change 56.89% 59.74% 2.03%
Cost Of Revenue $70.17M $66.59M $44.61M
YoY Change 54.02% 49.27% 0.27%
Gross Profit $35.04M $32.52M $17.44M
YoY Change 62.98% 86.53% 6.81%
Gross Profit Margin 33.3% 32.81% 28.1%
Selling, General & Admin $20.04M $18.52M $14.49M
YoY Change 39.33% 27.81% 3.85%
% of Gross Profit 57.21% 56.94% 83.09%
Research & Development $13.04M $12.11M $8.293M
YoY Change 49.52% 46.05% -21.55%
% of Gross Profit 37.22% 37.24% 47.57%
Depreciation & Amortization $2.300M $2.100M $1.700M
YoY Change 21.05% 23.53% 21.43%
% of Gross Profit 6.56% 6.46% 9.75%
Operating Expenses $33.08M $30.63M $22.78M
YoY Change 43.18% 34.45% -7.1%
Operating Profit $1.951M $1.893M -$5.345M
YoY Change -221.1% -135.42% -34.79%
Interest Expense -$600.0K $356.0K $437.0K
YoY Change -14.29% -18.54% -17.08%
% of Operating Profit -30.75% 18.81%
Other Income/Expense, Net -$1.134M -$953.0K -$815.0K
YoY Change 44.83% 16.93% 40.52%
Pretax Income $817.0K $940.0K -$6.160M
YoY Change -134.13% -115.26% -29.82%
Income Tax $415.0K $127.0K $141.0K
% Of Pretax Income 50.8% 13.51%
Net Earnings $402.0K $813.0K -$6.301M
YoY Change -114.31% -112.9% -29.26%
Net Earnings / Revenue 0.38% 0.82% -10.16%
Basic Earnings Per Share $0.02
Diluted Earnings Per Share $9.174K $0.02 -$150.7K
COMMON SHARES
Basic Shares Outstanding 43.62M shares 43.13M shares 41.78M shares
Diluted Shares Outstanding 48.79M shares 41.78M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $42.00M $44.50M $31.80M
YoY Change 9.95% 39.94% -23.74%
Cash & Equivalents $42.03M $44.54M $31.78M
Short-Term Investments
Other Short-Term Assets $6.200M $5.200M $3.200M
YoY Change 67.57% 62.5% -54.29%
Inventory $21.59M $15.49M $24.39M
Prepaid Expenses
Receivables $45.12M $49.27M $34.74M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $114.9M $114.5M $94.07M
YoY Change 26.94% 21.71% -4.11%
LONG-TERM ASSETS
Property, Plant & Equipment $30.82M $28.83M $24.82M
YoY Change 24.03% 16.12% -0.31%
Goodwill $3.745M
YoY Change
Intangibles $1.811M
YoY Change 533.22%
Long-Term Investments
YoY Change
Other Assets $916.0K $1.410M $1.420M
YoY Change -10.28% -0.7% 42.0%
Total Long-Term Assets $37.30M $30.24M $26.24M
YoY Change 42.57% 15.21% 0.93%
TOTAL ASSETS
Total Short-Term Assets $114.9M $114.5M $94.07M
Total Long-Term Assets $37.30M $30.24M $26.24M
Total Assets $152.2M $144.7M $120.3M
YoY Change 30.45% 20.29% -3.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.32M $21.99M $15.10M
YoY Change 203.08% 45.61% -0.64%
Accrued Expenses $26.04M $22.91M $20.91M
YoY Change 76.16% 9.55% 36.66%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $2.888M $3.432M
YoY Change -100.0% -15.85% -49.53%
Total Short-Term Liabilities $58.71M $57.95M $42.42M
YoY Change 75.95% 36.6% 11.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $2.973M $5.861M
YoY Change -100.0% -49.27% 14.92%
Other Long-Term Liabilities $3.589M $1.439M $435.0K
YoY Change 211.01% 230.8% -97.62%
Total Long-Term Liabilities $46.53M $4.412M $6.296M
YoY Change 7.97% -29.92% -73.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $58.71M $57.95M $42.42M
Total Long-Term Liabilities $46.53M $4.412M $6.296M
Total Liabilities $105.2M $102.3M $79.98M
YoY Change 37.64% 27.86% 29.83%
SHAREHOLDERS EQUITY
Retained Earnings -$161.0M -$161.4M -$150.1M
YoY Change 5.26% 7.5%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $46.95M $42.46M $40.33M
YoY Change
Total Liabilities & Shareholders Equity $152.2M $144.7M $120.3M
YoY Change 30.45% 20.29% -3.05%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income $402.0K $813.0K -$6.301M
YoY Change -114.31% -112.9% -29.26%
Depreciation, Depletion And Amortization $2.300M $2.100M $1.700M
YoY Change 21.05% 23.53% 21.43%
Cash From Operating Activities $8.900M $11.20M -$500.0K
YoY Change 17.11% -2340.0% -97.56%
INVESTING ACTIVITIES
Capital Expenditures -$3.400M -$5.500M -$1.400M
YoY Change 142.86% 292.86% -54.84%
Acquisitions
YoY Change
Other Investing Activities -$3.300M
YoY Change
Cash From Investing Activities -$6.700M -$5.500M -$1.400M
YoY Change 378.57% 292.86% -54.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.400M 1.600M -500.0K
YoY Change -4500.0% -420.0% -70.59%
NET CHANGE
Cash From Operating Activities 8.900M 11.20M -500.0K
Cash From Investing Activities -6.700M -5.500M -1.400M
Cash From Financing Activities -4.400M 1.600M -500.0K
Net Change In Cash -2.200M 7.300M -2.400M
YoY Change -134.92% -404.17% -90.51%
FREE CASH FLOW
Cash From Operating Activities $8.900M $11.20M -$500.0K
Capital Expenditures -$3.400M -$5.500M -$1.400M
Free Cash Flow $12.30M $16.70M $900.0K
YoY Change 36.67% 1755.56% -105.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
enph Increase Decreasein Product Warranty Accrual
IncreaseDecreaseinProductWarrantyAccrual
8028000 USD
enph Increase Decreasein Product Warranty Accrual
IncreaseDecreaseinProductWarrantyAccrual
1875000 USD
CY2014Q3 enph Line Of Credit Number Of Debt Agreements
LineOfCreditNumberOfDebtAgreements
3 debt_agreement
enph Product Warranty Accrual Accretion Expense
ProductWarrantyAccrualAccretionExpense
-87000 USD
enph Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0 USD
enph Product Warranty Accrual Accretion Expense
ProductWarrantyAccrualAccretionExpense
0 USD
CY2014Q3 enph Product Warranty Accrual Accretion Expense
ProductWarrantyAccrualAccretionExpense
-47000 USD
CY2013Q3 enph Product Warranty Accrual Accretion Expense
ProductWarrantyAccrualAccretionExpense
0 USD
CY2013Q4 enph Product Warranty Accrual Current Fair Value Disclosure
ProductWarrantyAccrualCurrentFairValueDisclosure
0 USD
CY2014Q3 enph Product Warranty Accrual Current Fair Value Disclosure
ProductWarrantyAccrualCurrentFairValueDisclosure
978000 USD
CY2014Q3 enph Product Warranty Accrual Noncurrent Fair Value Disclosure
ProductWarrantyAccrualNoncurrentFairValueDisclosure
1983000 USD
CY2013Q4 enph Product Warranty Accrual Noncurrent Fair Value Disclosure
ProductWarrantyAccrualNoncurrentFairValueDisclosure
0 USD
enph Product Warranty Accrual Other
ProductWarrantyAccrualOther
-164000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1111000 USD
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
351000 USD
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
447000 USD
enph Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisedin Period Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisedinPeriodFairValue
4500000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
40000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2847000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1815000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-270000 USD
CY2014Q3 enph Product Warranty Accrual Other
ProductWarrantyAccrualOther
-175000 USD
enph Product Warranty Accrual Other
ProductWarrantyAccrualOther
0 USD
CY2013Q3 enph Product Warranty Accrual Other
ProductWarrantyAccrualOther
0 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
192916000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7363000 USD
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
21992000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
32084000 USD
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49270000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14780000 USD
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22906000 USD
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-56000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
229000 USD
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
203911000 USD
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2530000 USD
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2045000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4955000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7037000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2000000 USD
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2241000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
256000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
322000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8770000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9926000 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9268000 shares
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
560000 shares
CY2013Q4 us-gaap Assets
Assets
116669000 USD
CY2014Q3 us-gaap Assets
Assets
144724000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
90509000 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
114489000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1291000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
305000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38190000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44537000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31778000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45294000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6347000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-13516000 USD
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42123000 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43378000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42123000 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43378000 shares
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications of prior year's balances have been made to conform to current year presentation, including separately presenting balances for &#8220;Warranty obligations&#8221; in current liabilities on the condensed consolidated balance sheets and under changes in operating assets and liabilities on the condensed consolidated statements of cash flows.</font></div></div>
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22958000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
521000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8739000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6197000 USD
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
66592000 USD
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
44611000 USD
us-gaap Cost Of Revenue
CostOfRevenue
119870000 USD
us-gaap Cost Of Revenue
CostOfRevenue
160689000 USD
CY2013Q3 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
141000 USD
CY2014Q3 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
127000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2773000 USD
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2418000 USD
CY2014Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
15339000 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
11284000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5122000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6004000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4955000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
4000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7037000 USD
CY2014Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
20700000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M5D
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-82000 USD
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-247000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8632000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17899000 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5937000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22837000 USD
us-gaap Gross Profit
GrossProfit
45920000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
32521000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
17435000 USD
us-gaap Gross Profit
GrossProfit
78008000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5345000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1893000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-20547000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-6380000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22656000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6160000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8103000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
940000 USD
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.56
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.20
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.15
CY2014Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.02
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.56
CY2014Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.02
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.20
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.15
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
257000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.50
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1005000 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
447000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
127000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
141000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
351000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
22638000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3827000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17897000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7666000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3700000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4835000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4549000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1092000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1867000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
969000 USD
us-gaap Interest Expense
InterestExpense
1291000 USD
us-gaap Interest Expense
InterestExpense
1385000 USD
CY2014Q3 us-gaap Interest Expense
InterestExpense
356000 USD
CY2013Q3 us-gaap Interest Expense
InterestExpense
437000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
15152000 USD
CY2014Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
12564000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
16580000 USD
CY2014Q3 us-gaap Inventory Net
InventoryNet
15488000 USD
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1428000 USD
CY2014Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2924000 USD
CY2014Q3 us-gaap Liabilities
Liabilities
102262000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
76463000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
144724000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
116669000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
33365000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
57953000 USD
CY2014Q3 us-gaap Loans Payable Current
LoansPayableCurrent
2888000 USD
CY2013Q4 us-gaap Loans Payable Current
LoansPayableCurrent
3507000 USD
CY2014Q3 us-gaap Long Term Debt
LongTermDebt
5861000 USD
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
8677000 USD
CY2014Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2888000 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3507000 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5170000 USD
CY2014Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2973000 USD
CY2014Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
2973000 USD
CY2013Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
5170000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-183000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9836000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4886000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8451000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15342000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-6301000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
813000 USD
us-gaap Net Income Loss
NetIncomeLoss
-8454000 USD
us-gaap Net Income Loss
NetIncomeLoss
-23103000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-953000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-815000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2109000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1723000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
30628000 USD
us-gaap Operating Expenses
OperatingExpenses
84388000 USD
us-gaap Operating Expenses
OperatingExpenses
66467000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
22780000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1307000 USD
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1410000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-285000 USD
CY2014Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-292000 USD
CY2013Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
104000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
145000 USD
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1439000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1154000 USD
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-378000 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-597000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-432000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-724000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9836000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4886000 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5194000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3655000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3958000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1672000 USD
CY2014Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
32307000 USD
CY2014Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
32969000 USD
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
21338000 USD
CY2013Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
29366000 USD
CY2013Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
30432000 USD
CY2013Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
26777000 USD
CY2014Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
7749000 USD
CY2013Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
4942000 USD
CY2013Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
8434000 USD
CY2013Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
25490000 USD
CY2014Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
24558000 USD
CY2013Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
20932000 USD
CY2013Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
3823000 USD
CY2014Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
1146000 USD
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
8537000 USD
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
5506000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24853000 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28825000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
711000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
665000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12112000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8293000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25803000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32346000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
165790000 USD
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
62046000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-161393000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-152939000 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
99113000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
238697000 USD
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8550000 USD
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9884000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22765000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
29205000 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
89100000 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8498000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8509000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.52
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.94
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.29
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.04
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41777000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43128000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42664000 shares
CY2013Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
2626000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
5311000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
6666000 USD
CY2014Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
3041000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
4802000 USD
CY2014Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1361000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
3112000 USD
CY2013Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1392000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
759000 shares
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
40206000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
42462000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events and apply judgments that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results could differ from these estimates. Significant estimates and assumptions by management affect the timing and amounts of revenue recognition, warranty obligations and expense and the carrying value of inventory.</font></div></div>
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41517000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48786000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42664000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41517000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41777000 shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001463101
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
43624571 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Enphase Energy, Inc.

Files In Submission

Name View Source Status
0001463101-14-000021-index-headers.html Edgar Link pending
0001463101-14-000021-index.html Edgar Link pending
0001463101-14-000021.txt Edgar Link pending
0001463101-14-000021-xbrl.zip Edgar Link pending
enph-20140930.xml Edgar Link completed
enph-20140930.xsd Edgar Link pending
enph-20140930_cal.xml Edgar Link unprocessable
enph-20140930_def.xml Edgar Link unprocessable
enph-20140930_lab.xml Edgar Link unprocessable
enph-20140930_pre.xml Edgar Link unprocessable
enph0930201410-q.htm Edgar Link pending
enph09302014ex101.htm Edgar Link pending
enph09302014ex311.htm Edgar Link pending
enph09302014ex312.htm Edgar Link pending
enph09302014ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vivintenphase.jpg Edgar Link pending
vivintsolar.jpg Edgar Link pending